Optimising Outcomes & Exploring Psychological Aspects of Alpha-mannosidosis

60 minutes
English
Rare Diseases
Alpha-Mannosidosis
AM

This 60-minute webinar, part of our Series 3 program, focuses on advancing the diagnosis and treatment of Alpha-Mannosidosis (AM). Led by Dr Julia B. Hennermann and Dr Sarah Haupenthal, the session explores how enzyme replacement therapy (ERT) plays a central role in managing AM, alongside the equally important dimension of psychological support. The programme highlights how combining medical treatment with mental health care and family support can optimise outcomes and improve patient well-being.

Summary

By the end of this webinar, participants will be able to:

  1. Understand the role of enzyme replacement therapy in the management of Alpha-Mannosidosis.
  2. Recognise the psychological symptoms associated with AM and their impact on patients and families.
  3. Explore strategies for integrating psychological and psychosocial support into patient management.
  4. Evaluate multidisciplinary approaches that combine medical and mental health care for improved outcomes.

Agenda (CEST):

  • 5 min – Introduction – Julia Hennermann
  • 25 min – The Role of Enzyme Replacement Therapy in Managing Alpha-Mannosidosis – Julia Hennermann
  • 20 min – Psychological Symptoms in Individuals with Alpha-Mannosidosis – Sarah Haupenthal
  • 10 min– Q&A – Both Speakers